Shake Shack
SHAK
$67.84
-2.72%
Shake Shack Inc. operates a fast-casual restaurant chain built around premium burgers, chicken sandwiches, crinkle-cut fries, frozen custard, and shakes, generating roughly $2.2 billion in system sales across 373 company-owned U.S. Shacks and 286 licensed units concentrated in international markets and travel hubs, with the bulk of revenue coming from direct restaurant sales and a smaller royalty stream from licensing. The brand is a differentiated premium player in the quick-service and fast-casual burger category, positioned above mass-market chains through all-natural, hormone- and antibiotic-free proteins and a founder-led, hospitality-centric identity that supports pricing power and unit-level economics above fast-food peers. The current investor debate centers on a sharp reset in near-term guidance and margin pressure that triggered a violent single-day selloff in May 2026 and a subsequent 28% drawdown, pitting believers in the long-term unit-growth runway and founder Danny Meyer's roughly $2 million open-market insider purchase against skeptics worried about operating cash flow deterioration and a still-demanding valuation. More recently, the narrative has shifted toward recovery, with the stock rebounding sharply off its summer lows as investors reassess whether the margin trough has passed and whether the aggressive expansion pipeline can reaccelerate earnings growth into 2027.…
SHAK
Shake Shack
$67.84
Related headlines
Investment Opinion: Should I buy SHAK Today?
The synthesized recommendation is Hold. The core thesis is that Shake Shack's revenue growth (17% YoY) and brand strength justify a premium multiple, but negative free cash flow and margin compression create near-term uncertainty that offsets the 15% upside to the $80.50 average analyst target. The consensus rating is Buy (mean 2.11), but the wide target range ($34-$126) signals low conviction.
Supporting evidence includes: (1) revenue growth of 17.16% YoY in Q2 2026, (2) gross margin of 68.54% in Q2 2026, (3) EV/EBITDA of 20.99x versus sector norms in the low-to-mid teens, and (4) implied upside of 15.0% to the average target. However, trailing PE of 71.2x and forward PE of 49.6x are rich, and TTM FCF of $9.8 million is negligible. The PEG ratio of 0.21 is misleading due to depressed trailing earnings.
The biggest risks are: (1) margin compression persisting, (2) free cash flow remaining negative, and (3) valuation de-rating if growth slows. The rating would upgrade to Buy if Q3 2026 shows margin expansion and positive FCF, or if the stock pulls back to the $55-60 range (near the 52-week low). It would downgrade to Sell if revenue growth decelerates below 10% or if FCF remains negative for another two quarters. Relative to its history, the stock is near the low end of its valuation range (PS of 2.26x vs. 15.07x a year ago), suggesting it is fairly valued to slightly undervalued on a historical basis, but still at a premium to peers.
Sign up to view all
SHAK 12-Month Price Forecast
The forward view is balanced: revenue growth is strong, but profitability and cash flow are weak, and the valuation remains rich. The stock's recent 23.55% one-month rally suggests the market is pricing in a margin recovery, but that recovery is not yet evident in the financials. I would upgrade to bullish if Q3 2026 shows margin expansion and positive FCF, and downgrade to bearish if revenue growth decelerates below 10% or if FCF remains negative for another two quarters. The risk/reward is roughly symmetric at current levels, with 15% upside to the base case and 26% downside to the bear case.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Shake Shack's 12-month outlook, with a consensus price target around $80.50 and implied upside of +18.7% versus the current price.
Average Target
$80.50
0 analysts
Implied Upside
+18.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$34 - $126
Analyst target range
Coverage is robust with 24 analysts, and the consensus recommendation is Buy (mean rating of 2.11 on a scale where lower is more bullish), with an average target price of $80.50 — implying roughly +15.0% upside from the current $69.99. The consensus leans moderately bullish, supported by a cluster of Buy/Outperform ratings from DA Davidson, BNP Paribas, Mizuho, Deutsche Bank, and Loop Capital, though the presence of Neutral ratings from JP Morgan, UBS, and Piper Sandler signals that the Street is not uniformly convinced the margin recovery is durable. Consensus 2027 revenue of $2.775 billion and EPS of $2.38 imply continued double-digit top-line growth with meaningful earnings recovery, which is the crux of the bull case.
The target range is extremely wide — from a low of $34.00 to a high of $126.00, a spread of nearly 4x the low end — which signals high uncertainty and low conviction in the out-year estimates. The high target of $126 assumes successful execution of the unit-growth pipeline, margin recovery toward historical levels, and multiple expansion back toward prior-cycle valuations, while the low target of $34 prices in persistent margin compression, negative free cash flow, and a de-rating toward restaurant-sector norms. Recent rating actions have been stable rather than directional — JP Morgan reiterated Neutral on September 29, 2026, and DA Davidson and BNP Paribas reiterated Buy/Outperform in early August — suggesting analysts are waiting for the next earnings print to validate the recovery before adjusting targets, and the wide dispersion argues for position sizing that respects the binary nature of the margin-recovery thesis.
Drowning in data?
Find the real signal!
Bulls vs Bears: SHAK Investment Factors
The bull case rests on accelerating revenue growth (17% YoY), founder insider buying, a consensus Buy rating with 15% upside, and a valuation that has compressed to multi-year lows. The bear case counters with negative free cash flow, margin compression that caused net income to decline despite revenue growth, a premium valuation (71x trailing PE), and high beta that amplifies downside. Currently, the bear evidence appears stronger on fundamentals—negative FCF and margin deterioration are concrete, while the bull case relies on recovery expectations. The single most important tension is whether the margin trough has passed: if Q3 2026 shows margin expansion and positive FCF, the stock could re-rate sharply; if not, the premium valuation and cash burn could drive another leg lower.
Bullish
- Revenue growth accelerating at 17% YoY: Q2 2026 revenue hit a record $417.6 million, up 17.16% from $356.5 million in Q2 2025 and up sequentially from $366.7 million in Q1 2026. This acceleration, driven by 373 company-owned U.S. Shacks and 286 licensed units, demonstrates the unit-growth engine is intact despite margin pressure.
- Founder insider buying signals confidence: Founder Danny Meyer purchased roughly $2 million of stock in the open market after the May 2026 28% drop, a strong signal that management sees the selloff as overdone. Insider buying at depressed prices often precedes fundamental recovery.
- Analyst consensus Buy with 15% upside: 24 analysts have a mean rating of 2.11 (Buy) and an average target price of $80.50, implying +15.0% upside from $69.99. The high target of $126 suggests significant upside if margin recovery materializes.
- Valuation near multi-year lows: PS ratio has compressed to 2.26x from 15.07x in Q2 2025 and 16.09x in Q4 2024, while P/B fell from 10.87x to 6.21x. This places the stock near the low end of its historical valuation band, potentially pricing in excessive pessimism.
Bearish
- Negative free cash flow despite revenue growth: TTM free cash flow is just $9.8 million, and Q2 2026 FCF was -$0.74 million after $57.7 million of capex against $57.0 million of operating cash flow. The capital-intensive unit-growth model is consuming cash, raising execution risk if growth slows.
- Margin compression eroding profitability: Q2 2026 net income of $15.68 million (3.75% margin) declined from $17.15 million (4.81% margin) in Q2 2025 despite 17% revenue growth. Labor, commodity, and pre-opening costs are squeezing margins, and Q1 2026 was essentially breakeven at -$0.29 million.
- Premium valuation leaves little room for error: Trailing PE of 71.2x and EV/EBITDA of 20.99x are roughly double the mid-30s PE and low-to-mid teens EV/EBITDA typical of fast-casual peers. The May 2026 guidance cut demonstrated how quickly the stock can de-rate when expectations are missed.
- High beta amplifies downside volatility: Beta of 1.677 means the stock is roughly 68% more volatile than the market. The max drawdown of -50.0% and 24.95% one-year decline versus SPY's 15.53% gain illustrate the severe relative underperformance and risk of further declines.
SHAK Technical Analysis
Shake Shack is in a damaged but repairing downtrend: the stock is down 24.95% over the trailing year versus a 15.53% gain for SPY, a relative strength gap of -40.48 percentage points, and it has fallen 16.15% year-to-date. At $69.99, the shares sit at roughly 34% of the 52-week range of $51.60 to $107.46, having lost more than half their value at the worst point (max drawdown of -50.0%), which places the stock in recovery territory rather than at momentum highs — a positioning that historically offers better risk/reward but also reflects a broken primary trend that has yet to reclaim its prior highs. The 52-week high of $107.46 remains 53.5% above the current price, underscoring how much ground must be recovered before the long-term downtrend is technically invalidated.
Short-term momentum is decisively positive and sharply divergent from the annual trend: the stock has gained 23.55% over the past month and 20.67% over three months, crushing SPY's 1.22% and 2.69% respective returns for relative strength of +22.33 and +17.98 points. This is a classic mean-reversion rally off a capitulation low — the May 2026 guidance-driven collapse took shares from $96.52 on May 6 to $52.34 by June 5, and the current advance has retraced a meaningful portion of that decline, with the stock printing a higher-low structure around $54.88 in mid-September before rallying to $71.06 on October 13. The 6-month change of -32.53% versus the 1-month gain of +23.55% confirms the divergence is a recovery within a larger drawdown rather than a new all-time-high trend, and the elevated beta of 1.677 means these swings are amplified roughly 68% beyond market moves.
Key technical levels are well defined: support sits at the 52-week low of $51.60, with secondary support near the September higher low around $54.88, while resistance is anchored at the 52-week high of $107.46 and, more immediately, the $75-$76 zone where the August rally stalled (the stock peaked at $75.82 on August 21 before rolling over). A breakout above $76 would signal the recovery has legs and open a path toward the $90s, whereas a breakdown below $51.60 would confirm the downtrend and likely trigger another leg lower. With a beta of 1.677, daily volume of roughly 1.32 million shares, and a short ratio of 2.47 days to cover, position sizing should account for above-market volatility — a 1.677 beta implies roughly 68% more price variability than SPY, meaning stops and sizing must be widened accordingly.
Beta
1.68
1.68x market volatility
Max Drawdown
-50.0%
Largest decline past year
52-Week Range
$52-$107
Price range past year
Annual Return
-27.5%
Cumulative gain past year
| Period | SHAK Return | S&P 500 |
|---|---|---|
| 1m | +19.1% | -0.1% |
| 3m | +21.2% | +4.7% |
| 6m | -34.1% | +8.3% |
| 1y | -27.5% | +15.2% |
| ytd | -18.7% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHAK Fundamental Analysis
Revenue is growing at a healthy clip but the trajectory is uneven: Q2 2026 (quarter ended July 1, 2026) revenue reached $417.6 million, up 17.16% year-over-year from $356.5 million in Q2 2025, and up sequentially from $366.7 million in Q1 2026. The multi-quarter trend shows acceleration from Q1 2026's $366.7 million (which itself grew from $320.9 million in Q1 2025) and Q4 2025's $400.5 million, with the Q2 2026 print the highest quarterly revenue on record in the provided data. Segment data shows the growth is overwhelmingly driven by company-operated Shack Sales of $403.4 million versus just $14.2 million in franchise revenue, meaning the investment case is a unit-growth and same-store-sales story rather than an asset-light royalty model — a capital-intensive mix that explains the heavy capex burden discussed below.
Profitability is thin but improving off a weak base: Q2 2026 net income was $15.68 million (net margin 3.75%) on gross profit of $286.2 million, a 68.54% gross margin, with operating income of $20.75 million (4.97% operating margin) and EBITDA of $48.86 million (11.70% EBITDA margin). The prior quarter, Q1 2026, was essentially breakeven at -$0.29 million net income (net margin -0.08%) with a 47.44% gross margin, while Q2 2025 delivered $17.15 million of net income (4.81% margin) — so year-over-year net income actually declined despite 17% revenue growth, evidence of margin compression from labor, commodity, and pre-opening costs. The trailing net margin of 3.16% and operating margin of 5.93% are well below what a mature fast-casual operator typically earns, leaving substantial room for operating leverage if traffic and pricing hold.
Balance sheet and cash flow are the pressure point: debt-to-equity stands at 1.72x, the current ratio is a comfortable 1.76x, and cash on hand was $308.0 million at the end of Q2 2026, but free cash flow is deeply negative — TTM FCF of just $9.8 million and Q2 2026 FCF of -$0.74 million after $57.7 million of capex against $57.0 million of operating cash flow. ROE is only 8.70% and ROA 1.98%, reflecting the capital intensity of new-unit construction, and the Q1 2026 quarter saw FCF of -$17.17 million on $47.2 million of capex. The company is funding growth largely from its cash pile and operating cash flow rather than free cash flow, which raises execution risk if the unit-growth pipeline slows or if capex overruns persist — the FCF yield is effectively negligible at current levels.
Quarterly Revenue
$417618000.0B
2026-07
Revenue YoY Growth
+17.2%
YoY Comparison
Gross Margin
68.5%
Latest Quarter
Free Cash Flow
$9821000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHAK Overvalued?
Because Shake Shack is profitable on a trailing basis (net income positive), the PE ratio is the appropriate primary metric: the trailing PE is 71.2x versus a forward PE of 49.6x, a gap that implies the market expects roughly 44% earnings growth over the next twelve months, consistent with consensus EPS of $2.38 versus trailing EPS of about $0.98. The forward multiple of 49.6x is still rich for a restaurant operator, and the PEG ratio of 0.21 looks optically cheap only because it is calculated off a depressed trailing earnings base — a reminder that PEG is unreliable when the denominator is near a trough.
Against the sector, the stock trades at a premium on most measures: PS of 2.26x, EV/Sales of 2.27x, EV/EBITDA of 20.99x, and P/B of 6.21x, with a trailing PE of 71.2x that is roughly double the mid-30s multiple typical of large-cap fast-casual peers. The premium is partially justified by Shake Shack's superior unit-growth runway and brand strength, but the 20.99x EV/EBITDA multiple versus a restaurant sector norm in the low-to-mid teens represents a meaningful growth premium that leaves little room for execution error — as the May 2026 guidance cut demonstrated.
Historically, the stock's own valuation band has compressed dramatically: PS was 15.07x in Q2 2025 and 16.09x in Q4 2024, versus 2.26x today, and PE has fallen from 77.8x in Q2 2025 to 71.2x now while P/B dropped from 10.87x to 6.21x. This places the stock near the low end of its multi-year valuation range, which can signal either a genuine value opportunity or fundamental deterioration — given the negative FCF and margin compression, the market is pricing in skepticism about the growth story rather than euphoria, making the current multiple a bet on execution recovery rather than multiple expansion.
PE
71.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 36x~212x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant: TTM free cash flow is only $9.8 million, and Q2 2026 FCF was -$0.74 million after $57.7 million of capex, meaning the company is funding growth from its cash pile ($308 million) rather than internally generated cash. Debt-to-equity stands at 1.72x, and ROE is just 8.70%, reflecting the capital intensity of new-unit construction. Margin compression is evident: Q2 2026 net margin of 3.75% declined from 4.81% a year earlier despite 17% revenue growth, and Q1 2026 was essentially breakeven. Revenue is heavily concentrated in company-operated Shack Sales ($403.4 million vs. $14.2 million franchise revenue), making the company vulnerable to labor and commodity cost inflation.
Market and competitive risks include valuation compression: trailing PE of 71.2x and EV/EBITDA of 20.99x are roughly double peer norms, leaving little room for execution error. The May 2026 guidance cut triggered a 28% single-day drop, demonstrating how quickly the stock can de-rate. Beta of 1.677 means the stock is 68% more volatile than the market, and the 24.95% one-year decline versus SPY's 15.53% gain reflects severe relative underperformance. Rising oil prices (noted in March 2026 news) could pressure operational costs, and the competitive fast-casual burger space requires continuous innovation to maintain pricing power.
Worst-case scenario: A sustained margin compression combined with slowing unit growth could lead to a de-rating toward restaurant-sector norms. The 52-week low of $51.60 represents a 26.3% decline from the current $69.99, and the analyst low target of $34 implies a 51.4% downside. If Q3 2026 earnings miss and management guides down again, the stock could retest the $51.60 low, and a break below could trigger another leg lower toward the $34 bear-case target. Investors could lose 26-51% from current levels in this adverse scenario.
FAQ
The key risks are: (1) Financial: negative free cash flow (TTM FCF of $9.8 million) and high debt-to-equity of 1.72x; (2) Operational: margin compression, with Q2 2026 net margin of 3.75% down from 4.81% a year earlier; (3) Market: high beta of 1.677 amplifies downside, and the stock has a max drawdown of -50%; (4) Valuation: premium multiples (71x PE) leave little room for error, as shown by the 28% drop in May 2026. The most severe risk is a prolonged margin compression that forces another guidance cut, which could drive the stock toward the $34 analyst low target.
The 12-month forecast has three scenarios: Bull (25% probability) with a target range of $95-$126, Base (50%) with $75-$85, and Bear (25%) with $34-$52. The base case is most likely, assuming revenue growth of 12-15% and gradual margin recovery, with the stock gravitating toward the $80.50 average analyst target. The bull case requires a margin recovery and positive FCF, while the bear case assumes persistent margin pressure and another guidance cut. The key assumption for the base case is that Q3 2026 earnings show margin stabilization and no further guidance cuts.
SHAK is overvalued on most current metrics but fairly valued relative to its own history. The trailing PE of 71.2x and EV/EBITDA of 20.99x are roughly double peer norms, indicating a premium. However, the PS ratio of 2.26x is far below its historical levels of 15.07x in Q2 2025 and 16.09x in Q4 2024, suggesting the stock has de-rated significantly. The forward PE of 49.6x implies the market expects 44% earnings growth, which is achievable if margins recover. Overall, the stock is pricing in a recovery, so it is not cheap on an absolute basis but may be undervalued if the recovery materializes.
SHAK is a good buy only for investors with a high risk tolerance and a long-term horizon. The stock offers 15% upside to the average analyst target of $80.50, but the downside risk to the 52-week low of $51.60 is 26%. The company's revenue growth of 17% YoY is impressive, but negative free cash flow and margin compression are concerns. The consensus rating is Buy, but the wide target range ($34-$126) signals uncertainty. A patient investor could accumulate on dips near $55-60, but a safer entry would be after evidence of margin recovery in Q3 2026 earnings.
SHAK is more suitable for long-term investment (minimum 2-3 years) given its growth stage, high volatility (beta 1.677), and no dividend. The company is still expanding its unit base and investing heavily in capex, which suppresses near-term free cash flow but should drive future earnings. Short-term trading is risky due to the high beta and wide analyst target dispersion. Earnings visibility is low, with the stock prone to sharp moves around quarterly reports. A suggested minimum holding period is 2-3 years to allow the unit-growth pipeline to mature and margins to recover.